• Home
  • About us
    • Our history
    • Our team
  • Science
    • Neuroprotection
    • Immune Modulation
  • Pipeline
  • Partners
  • Newsroom

Our partners

  • Partners
  • Public funding
  • Investors

Partners

Vall d'Hebron University Hospital

La Princesa University Hospital

Germans Trias i Pujol University Hospital

Virgen del Rocío University Hospital - Institute of Biomedicine of Seville (IBiS)

Virgen Macarena University Hospital

Aptus Biotech

Complutense University of Madrid - School of Medicine

Institute of Biomedical Research Alberto Sols (IIBM - CSIC)

Francisco de Vitoria University

Cajal Institute (IC - CSIC)

Ramón y Cajal University Hospital - Ramón y Cajal Health Research Institute (IRYCIS)

La Fe University Hospital

Revio Pharmaceutical Consultants

Public funding

EIC Accelerator

Programa Neotec
Programa PID
Programa Cervera

Programa Retos-Colaboración Programa Torres Quevedo

Programa Doctorados Industriales

Programa Retos-Colaboración 2021 (Proyecto TollMark) Programa Torres Quevedo

Líneas Enisa 2021

Programa Misiones Ciencia e Innovación (Plan Estatal I+D+I)

Programa Cheque Innovación 2021

Investors

This company is capitalized by Innvierte, an investment program of CDTI (Spanish Ministry for Science and Innovation)

Aptatargets
Copyright © 2020 AptaTargets SL. All Right Reserved.
  • Home
  • Contact Us
  • Cookies policy
  • Legal notice
We use our own and third-party cookies to improve our services and show commercials related to your own preferences through the analysis of your browsing habits. Clicking Accept entails your acceptance in using them.
You can change this configuration or obtain additional information on legal warning.
ACCEPT